Amit Garg - Academia.edu (original) (raw)
Uploads
Papers by Amit Garg
Journal of postgraduate medicine
India has more than 20,000 registered pharmaceutical manufacturers. Consequently, there is a floo... more India has more than 20,000 registered pharmaceutical manufacturers. Consequently, there is a flood of brand names to choose from. We conducted this study to analyse and sort out the multitudinous brand names thronging the Indian market, and identified those that could create a possible confusion. Recent issues of drug formularies like Indian Drug Review, Drug Index, and Monthly Index of Medical Specialities-India were checked and all the brand names given were included. Some other brand names that are available with the pharmacists but are not included in these indexes were also included in the study for analysis. Potentially confusing brand names were sorted out and categorised according to the severity of damage they can cause if misinterpreted by the pharmacist or the patient. Subgroups were made according to the brand name, the generic name, and the manufacturers of the drug. Several brand names are strikingly identical, similar looking (orthographic), or similar sounding (phono...
Laser-Induced Damage in Optical Materials: 2003, 2004
Multiple pulse damage in mirror polished samples of Mercury Cadmium Telluride & Cadmi... more Multiple pulse damage in mirror polished samples of Mercury Cadmium Telluride & Cadmium Telluride at damage threshold has been studied using a 1.06 mum Nd: YAG laser of 35ps pulse duration. Damage morphology observed under Scanning Electron Microscope (SEM) is same for both HgCdTe & CdTe. It shows formation of a typical forest of micro-columnar structures which are aligned along
The Journal of Clinical Pharmacology, 2011
Anacetrapib (MK-0859) is a potent and selective inhibitor of cholesteryl ester transfer protein (... more Anacetrapib (MK-0859) is a potent and selective inhibitor of cholesteryl ester transfer protein (CETP) currently undergoing development as an oral drug for the treatment of primary hypercholesterolemia and mixed hyperlipidemia. 1-4 A midazolam probe study demonstrated that anacetrapib ...
Journal of postgraduate medicine
India has more than 20,000 registered pharmaceutical manufacturers. Consequently, there is a floo... more India has more than 20,000 registered pharmaceutical manufacturers. Consequently, there is a flood of brand names to choose from. We conducted this study to analyse and sort out the multitudinous brand names thronging the Indian market, and identified those that could create a possible confusion. Recent issues of drug formularies like Indian Drug Review, Drug Index, and Monthly Index of Medical Specialities-India were checked and all the brand names given were included. Some other brand names that are available with the pharmacists but are not included in these indexes were also included in the study for analysis. Potentially confusing brand names were sorted out and categorised according to the severity of damage they can cause if misinterpreted by the pharmacist or the patient. Subgroups were made according to the brand name, the generic name, and the manufacturers of the drug. Several brand names are strikingly identical, similar looking (orthographic), or similar sounding (phono...
Laser-Induced Damage in Optical Materials: 2003, 2004
Multiple pulse damage in mirror polished samples of Mercury Cadmium Telluride & Cadmi... more Multiple pulse damage in mirror polished samples of Mercury Cadmium Telluride & Cadmium Telluride at damage threshold has been studied using a 1.06 mum Nd: YAG laser of 35ps pulse duration. Damage morphology observed under Scanning Electron Microscope (SEM) is same for both HgCdTe & CdTe. It shows formation of a typical forest of micro-columnar structures which are aligned along
The Journal of Clinical Pharmacology, 2011
Anacetrapib (MK-0859) is a potent and selective inhibitor of cholesteryl ester transfer protein (... more Anacetrapib (MK-0859) is a potent and selective inhibitor of cholesteryl ester transfer protein (CETP) currently undergoing development as an oral drug for the treatment of primary hypercholesterolemia and mixed hyperlipidemia. 1-4 A midazolam probe study demonstrated that anacetrapib ...